Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-10

FDA Approved: AMLODIPINE BESYLATE — Original Application (Exelan Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves the Original Application for amlodipine besylate, a generic version of the calcium channel blocker used to treat hypertension and certain types of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

ORIG AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)